Appointments to bolster rapid scaling and execution of Pyxa™ spatial platform BOSTON — Stellaromics, a pioneer in high-resolution 3D spatial multi-omics, today announced the appointment of Stacie Weninger, PhD, and Steve McPhail to its Board of Directors. These strategic appointments come at a pivotal time for the company as it scales its innovative Pyxa™ technology and […]

Dr. Matt McManus to transition from his role as President, Diagnostics and Spatial Biology Segment, effective March 1, 2026 Steve Crouse, Senior Vice President of Bio-Techne’s Analytical Solutions Division, has been appointed President, Diagnostics and Spatial Biology Segment, effective March 1, 2026 MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that Dr. Matt McManus, President […]

Schlieren, Switzerland — InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed a partnership with PharmaNest Inc, a Princeton, NJ-based digital pathology company. This partnership uniquely positions InSphero’s in the space of the translational application of machine learning tools in combination with human pre-clinical models to decipher complex pathological phenotypes for the identification of effective therapies. A key challenge of these current unmet clinical needs is the prediction of the drug efficacy of complex fibrotic phenotypes in clinical stages. The […]

LEIDEN, the Netherlands — Today marks an important step for the global microphysiological systems (MPS) field with the launch of IAMPS – the Industry Alliance for Microphysiological Systems – the world’s first industry association dedicated to advancing MPS technologies. With MIMETAS as a founding member, IAMPS brings together nine pioneering companies – AlveoliX (Switzerland), BiomimX (Italy), chiron (Netherlands), Dynamic42 […]

Produces 35–500 liters of sterile media and buffers on demand at point-of-use, reducing cost, complexity, and lead times Pod-based, closed single-use system with integrated analytics, QR-code-driven execution, and automated digital batch records to support GMP-compliant manufacturing SAN DIEGO — Nucleus Biologics, a leading provider of custom cell culture solutions and manufacturing technologies for advanced therapies, […]

San Diego, CA — CellarisBio today announced the issuance of its flagship U.S. patent covering the MICRO-TAG® technology platform and the commercial launch of its first MICRO-TAG® reagent product line at the SLAS 2026 International Conference & Exhibition in Boston. These milestones position MICRO-TAG® as a real-time cellular target engagement platform for drug discovery across both […]

A new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and high-resolution imaging in a single 3D cell culture plate Monmouth Junction, NJ — TheWell Bioscience today announced the launch of the VitroPrime™ 3D Culture and Imaging Plate, a next-generation 3D cell culture plate engineered to support organoid and advanced 3D cell culture workflows with minimal […]

TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discovery MADISON, Wis. — Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins. The TarSeer™ BRETSA™ Target Engagement System is a novel bioluminescence resonance energy transfer-based […]

Integrated Platform Enables up to 3X Higher Throughput for Antibody Discovery and Characterization; Joint Solution Addresses Growing Demand from AI Drug Design Companies, Pharma, and CROs PALO ALTO, CA and SPRINGFIELD, NJ – Gator Bio, a leader in biolayer interferometry (BLI) systems, and Hudson Lab Automation, Inc., a leading laboratory automation provider, today announced the availability […]

Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications Announces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials Sciences MILFORD, Mass. — Waters Corporation (NYSE: WAT) (“Waters”) today announced it has completed […]